Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 7/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 5/20 | 0.58 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.57 |
| ▸ | NPY1R | P25929 | 1/20 | 0.56 |
| ▸ | NPY2R | P49146 | 1/20 | 0.56 |
| ▸ | NPY4R | P50391 | 1/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.56 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.56 |
| ▸ | EED | O75530 | 1/20 | 0.55 |
| ▸ | MC4R | P32245 | 2/20 | 0.53 |
| ▸ | MC5R | P33032 | 2/20 | 0.53 |
| ▸ | MC3R | P41968 | 2/20 | 0.53 |
| ▸ | MC1R | Q01726 | 2/20 | 0.53 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29845337 | 0.89 | CXCR4 (0.58) | CXCR4KISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL31232547 | 0.88 | C5AR1 (0.62) | CXCR4IL23RNPY1RNPY2RNPY4R | |
| SCHEMBL31410855 | 0.87 | KISS1R (0.65) | KISS1RIL23RNPY1RNPY2RNPY4R | |
| SCHEMBL30432221 | 0.87 | IL23R (0.62) | CXCR4IL23RNPY1RNPY2RNPY4R | |
| SCHEMBL30799900 | 0.87 | IL23R (0.68) | CXCR4IL23RNPY1RNPY2RNPY4R | |
| SCHEMBL30381557 | 0.87 | KISS1R (0.59) | CXCR4KISS1RIL23RNPY1RNPY2R | |
| SCHEMBL29845535 | 0.87 | CXCR4 (0.60) | CXCR4KISS1RNPY1RNPY2RNPY4R | |
| SCHEMBL29558373 | 0.86 | CAPN1 (0.61) | KISS1RCXCL8 | |
| SCHEMBL30575223 | 0.86 | C5AR1 (0.64) | CXCR4IL23RNPY1RNPY2RNPY4R | |
| SCHEMBL30673321 | 0.86 | CXCR4 (0.60) | CXCR4KISS1RIL23RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116490215-A | Targeted mediated endocytic drug delivery | CRM医疗有限公司 | 2023-07-25 | — | — | CN | disclosed |